CDIO: Cardio Diagnostics Holdings, Inc. P/S Multiple

Symbol and logo of brand Cardio Diagnostics (CDIO)

Cardio Diagnostics (CDIO) leverages AI in epigenetic testing to implement premium pricing, although the price/sales multiple exhibits volatility, currently standing at 278.00. Slow technology adoption by clinics and a liquidity shortage are constraining growth. Business stability is maintained through the optimization of biomaterial logistics and an extensive network of partner laboratories, which minimizes operational risks.

CDIO: Cardio Diagnostics Holdings, Inc. P/S Multiple 11/15/2023 - 11/13/2026

Metric breakdowns and analytics for Cardio Diagnostics (CDIO)

- market price and analyst price targets:
Stock Quotes cardiodiagnosticsinc.com|CDIO - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Cardio Diagnostics|CDIO - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Cardio Diagnostics|CDIO - Book Capitalization|Capitalization to Book Value Ratio cardiodiagnosticsinc.com|CDIO - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Cardio Diagnostics|CDIO - Long-Term Debt to Equity|Current Liabilities to Capital cardiodiagnosticsinc.com|CDIO - Company Total Debt|Debt to Net Assets Ratio Cardio Diagnostics|CDIO - Company Long-Term Debts|Company Short-Term Indebtedness Cardio Diagnostics|Interim Coverage Ratio cardiodiagnosticsinc.com
- earnings and valuation multiples information:
CDIO - Net Profit|Projected Future Earnings Cardio Diagnostics|CDIO - P/E Multiple|Forward Price to Earnings Multiple cardiodiagnosticsinc.com|CDIO - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Cardio Diagnostics|CDIO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Cardio Diagnostics|CDIO - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months cardiodiagnosticsinc.com|CDIO - Net earnings per share growth this year|Projected earnings per share increase next year Cardio Diagnostics
- issuer revenue and sales details:
CDIO - Revenue and Sales Volume|Company Future Sales cardiodiagnosticsinc.com|CDIO - P/S Multiple|Forward Price-to-Revenue Multiple Cardio Diagnostics
Summary company analytics:Cardio Diagnostics Holdings Inc., CDIO
Core merchandise of Cardio Diagnostics Holdings, Inc.

The scaling of cloud capacities at Cardio Diagnostics (CDIO) for continuous genetic analysis directly impacts revenue growth rates, which the market prices in through market capitalization. By analyzing the price-to-sales multiple, an investor correlates the current business value with actual sales volume, eliminating time lags between reports and identifying whether the asset is overvalued relative to its operational efficiency.

Competing companies

Market Cap to Revenue agilent.com A|P/S Multiple DGX (Quest Diagnostics Incorporated)|P/S Multiple Illumina Inc ILMN|EXAS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio RVTY (Revvity Corp)|BIO: P/S Multiple|Market Cap to Revenue Ratio NNNN|SHC (Sotera Health) - P/S Multiple|Quidel Corporation (QDEL) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio OPKO Corp (OPK)|CDNA - Price to Sales|Maravai LifeSciences - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FLGT|Standard BioTools - P/S Multiple|CTKB (Cytek Biosciences Inc) - Market Cap to Revenue Ratio|OSUR: P/S Multiple|XGN - Price-to-Revenue Coefficient|MDXH (MDxHealth SA) - P/S Multiple|P/S Multiple luciddx.com|P/S Multiple PRE|imdxinc.com (IMDX) - Price-to-Revenue Multiple|Price-to-Revenue Ratio Trinity Biotech TRIB|PRPH: Market Cap to Revenue Ratio|AIMD - Price-to-Revenue Ratio|Price to Sales codiagnostics.com|HeartSciences (HSCS) - Price-to-Revenue Ratio|BMRA - Price-to-Revenue Coefficient|Market Cap to Revenue ONCO|VRAX (Virax Biolabs Corp) - Market Cap to Sales Volume|P/S Multiple BJDX|Price-to-Revenue Coefficient aspirawh.com|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|CNTG - Market Cap to Revenue|ENZ - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Fresh2 Group Limited FRES|GENE: P/S Multiple|Market Cap to Revenue 23andme.com|PMD (Psychemedics Corporation) - P/S Multiple